StockData
Kiora Pharmaceuticals Inc logo

Kiora Pharmaceuticals Inc (KPRX) stock

KPRXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as KPHMW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$0.93−0.05 (-5.30%)

Close on Nov 17, 2026Market cap $4.11MP/E –Yield –

Kiora Pharmaceuticals total assets

Total assets on the balance sheet at the end of each period.

Kiora Pharmaceuticals's total assets was $23.78M at Jun 30, 2026. For fiscal 2025 it was $24.25M, down 33.5% from the year before. Over ten years it grew 9.8% a year on average. The highest annual figure on record is $36.48M in fiscal 2024.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$24.25M-33.5%
FY2024Dec 31, 2024$36.48M+166.1%
FY2023Dec 31, 2023$13.71M-26.6%
FY2022Dec 31, 2022$18.68M-7.2%
FY2021Dec 31, 2021$20.13M+31.5%
FY2020Dec 31, 2020$15.30M+51.3%
FY2019Dec 31, 2019$10.11M-29.2%
FY2018Dec 31, 2018$14.28M-0.2%
FY2017Dec 31, 2017$14.31M+47.0%
FY2016Dec 31, 2016$9.73M+2.3%
FY2015Dec 31, 2015$9.51M+576.0%
FY2014Dec 31, 2014$1.41M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$23.78M-25.6%
Q1 FY2026Mar 31, 2026$21.23M-37.6%
Q4 FY2025Dec 31, 2025$24.25M-33.5%
Q3 FY2025Sep 30, 2025$29.86M-22.5%
Q2 FY2025Jun 30, 2025$31.95M-21.7%
Q1 FY2025Mar 31, 2025$34.02M-19.8%
Q4 FY2024Dec 31, 2024$36.48M+166.1%
Q3 FY2024Sep 30, 2024$38.51M+142.3%
Q2 FY2024Jun 30, 2024$40.81M+105.3%
Q1 FY2024Mar 31, 2024$42.44M+156.8%
Q4 FY2023Dec 31, 2023$13.71M-26.6%
Q3 FY2023Sep 30, 2023$15.90M-10.0%
Q2 FY2023Jun 30, 2023$19.88M+28.6%
Q1 FY2023Mar 31, 2023$16.53M-6.3%
Q4 FY2022Dec 31, 2022$18.68M-7.2%
Q3 FY2022Sep 30, 2022$17.66M-30.7%
Q2 FY2022Jun 30, 2022$15.46M-14.6%
Q1 FY2022Mar 31, 2022$17.64M-14.5%
Q4 FY2021Dec 31, 2021$20.13M+31.5%
Q3 FY2021Sep 30, 2021$25.49M+175.7%
Q2 FY2021Jun 30, 2021$18.10M+65.0%
Q1 FY2021Mar 31, 2021$20.62M+69.2%
Q4 FY2020Dec 31, 2020$15.30M+51.3%
Q3 FY2020Sep 30, 2020$9.25M+4.3%
Q2 FY2020Jun 30, 2020$10.97M+0.7%
Q1 FY2020Mar 31, 2020$12.19M-2.0%
Q4 FY2019Dec 31, 2019$10.11M-29.2%
Q3 FY2019Sep 30, 2019$8.87M-46.7%
Q2 FY2019Jun 30, 2019$10.90M-42.8%
Q1 FY2019Mar 31, 2019$12.44M+11.4%
Q4 FY2018Dec 31, 2018$14.28M-0.2%
Q3 FY2018Sep 30, 2018$16.65M+3.7%
Q2 FY2018Jun 30, 2018$19.06M+4.1%
Q1 FY2018Mar 31, 2018$11.17M-7.0%
Q4 FY2017Dec 31, 2017$14.31M+47.0%
Q3 FY2017Sep 30, 2017$16.06M+51.3%
Q2 FY2017Jun 30, 2017$18.31M–
Q1 FY2017Mar 31, 2017$12.00M–
Q4 FY2016Dec 31, 2016$9.73M–
Q3 FY2016Sep 30, 2016$10.62M–

More Kiora Pharmaceuticals figures

See a number that looks wrong?